Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions-reply
Author:
Publisher
Springer Science and Business Media LLC
Subject
Emergency Medicine,Internal Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11739-021-02677-0.pdf
Reference5 articles.
1. Pardo-Cabello AJ, Manzano-Gamero V, Belda-Rustarazo S, Giner-Escobar P (2021) Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment. Intern Emerg Med. https://doi.org/10.1007/s11739-021-02645-8
2. Crescioli G, Brilli V, Lanzi C et al (2020) Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions. Intern Emerg Med. https://doi.org/10.1007/s11739-020-02586-8
3. Careggi University Hospital (2020) Smart Consensus Conference COVID-19 AOUC. https://www.youtube.com/watch?v=9kN6eUjAFUQ&list=PLeNf4JKSus9nv8t8CkjCYup-3jgxdEEAV. Accessed 10 Feb 2021
4. Italian Medicines Agency (2020) Medicines usable for treatment of COVID-19 disease. https://www.aifa.gov.it/en/aggiornamento-sui-farmaci-utilizzabili-per-il-trattamento-della-malattia-covid19. Accessed 10 Feb 2021
5. Lombardi N, Crescioli G, Bettiol A et al (2020) Italian Emergency Department Visits and Hospitalizations for Outpatients’ adverse drug events: 12-year active pharmacovigilance surveillance (the MEREAFaPS study). Front Pharmacol. https://doi.org/10.3389/fphar.2020.00412
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exposures and Suspected Intoxications to Pharmacological and Non-Pharmacological Agents in Children Aged 0–14 Years: Real-World Data from an Italian Reference Poison Control Centre;Journal of Clinical Medicine;2023-01-02
2. Pharmacovigilance and Pharmacoepidemiology as a Guarantee of Patient Safety: The Role of the Clinical Pharmacologist;Journal of Clinical Medicine;2022-06-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3